1-1 of 1
Giovanni Gallotta, MD
Close
Sort by
Journal Articles

Subcutaneous Alemtuzumab as Treatment Option for Patients with Severe Aplastic Anemia or Lineage-Restricted Aplasia.

Antonio M. Risitano, MD, PhD, Carmine Selleri, MD, Andrea Camera, MD, Giovanni Gallotta, MD, Fabiana Perna, MD, Giampaolo Copeta, MD, Bruno Rotoli, MD
Journal: Blood
Blood (2006) 108 (11): 3754.
https://doi.org/10.1182/blood.V108.11.3754.3754
Published: 2006